年最新溃疡性结肠炎治疗指南Ulcerativecolitis(UC)isachronicinflammatoryboweldiseaseharacterizedbyarelapsingandremittingcourse.ThedirectandindirectcostsofthetreatmentofUCarehigh,andthequalityoflifeofpatientsisreduced,especiallyduringexacerbationofthedisease.TheincidenceandprevalenceofUCinKoreaarestilllowerthanthoseofWesterncountries,buthavebeenrapidlyincreasingduringthepastdecades.Variousmedicalandsurgicaltherapies,includingbiologics,arecurrentlyusedforthemanagementofUC.However,manychallengingissuesexist,whichsometimesleadtodifferencesinpracticebetweenclinicians.Therefore,theIBDstudygroupoftheKoreanAssociationfortheStudyofIntestinalDiseasesestablishedthefirstKoreanguidelinesforthemanagementofUCin.Thisisanupdateofthefirstguidelines.Itwasgenerallymadebytheadaptationofseveralforeignguidelinesaswasthefirstedition,anden
转载注明：
http://www.hwsak.com/zcyby/10383781.html
